Men who have had testicular cancer have an increased likelihood of developing cancer in the remaining testicle. They also have an increased risk of certain types of leukemia, as well as other types of cancers. Regular followup care ensures that any changes in health are discussed, and any recurrent cancer can be treated as soon as possible. Participation in clinical trials is an important treatment option for many men with testicular cancer. To develop new, more effective treatments, and better ways to use current treatments, the National Cancer Institute is sponsoring clinical trials in many hospitals and cancer centers around the country.
Clinical trials are a critical step in the development of new methods of treatment.
Before any new treatment can be recommended for general use, doctors conduct clinical trials to find out whether the treatment is safe for patients and effective against the disease. Information specialists translate the latest scientific information into understandable language and respond in English, Spanish, or on TTY equipment. Includes information on understanding trials, deciding whether to participate in trials, finding specific trials, plus research news and other resources. CancerMail Includes NCI information about cancer treatment, screening, prevention, and supportive care. CancerFax Includes NCI information about cancer treatment, screening, prevention, and supportive care.